Sanofi Is Now the Third Insulin Producer to Slash Prices

Sanofi will cut the U.S. list price of two of its insulins, making it the third major producer of the diabetes medicine to recently slash prices. French pharmaceutical maker Sanofi will reduce the U.S. list price of Lantus, its most-prescribed insulin, by 78%, according to a statement Thursday. The company will also reduce the list … Read more

U.S. Maternal Mortality Rate Soared 40% During the Pandemic

The U.S. maternal mortality rate, already far higher than peer countries, soared during the pandemic. More than 1,200 women in the U.S. died of complications arising from pregnancy or childbirth in 2021, a 40% jump from 2020, according to data released Thursday by the U.S. Centers for Disease Control and Prevention. That amounts to 32.9 … Read more

Pfizer’s Bivalent COVID-19 Booster Gets FDA Nod for Infants and Toddlers

Pfizer Inc.’s bivalent shot for COVID-19 has received emergency approval to be used as a booster in some infants and toddlers. Children between six months and four years old can receive the Pfizer-BioNTech SE shot at least two months after completing their primary series of vaccinations, the U.S. Food and Drug Administration said Tuesday. Kids … Read more

The VA Will Pay for Some to Get New Alzheimer’s Drug

The U.S. Veterans Health Administration will pay for some beneficiaries to get a new Alzheimer’s disease drug from Eisai Co. and Biogen Inc., a move toward broader coverage of the controversial drug category. The VA added Leqembi, which received accelerated approval from the Food and Drug Administration in January, to its list of nonformulary drugs. … Read more